Advertisement

Osteoporosis International

, 20:1921 | Cite as

Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research

  • J. R. CurtisEmail author
  • T. Arora
  • J. Xi
  • A. Silver
  • J. J. Allison
  • L. Chen
  • K. G. Saag
  • A. Schenck
  • A. O. Westfall
  • C. Colón-Emeric
Original Article

Abstract

Summary

Using data from long-term glucocorticoid users and long-term care residents, we evaluated osteoporosis prescribing patterns related to physician behavior and common practice settings. We found no significant clustering effect for common practice setting, suggesting that osteoporosis quality improvement (QI) efforts may be able to ignore this factor in designing QI interventions.

Introduction

Patients’ receipt of prescription therapies are significantly influenced by their physician’s prescribing patterns. If physicians in the same practice setting influence one another’s prescribing, evidence implementation interventions must consider targeting the practice as well as individual physicians to achieve maximal success.

Methods

We examined receipt of osteoporosis treatment (OP Rx) from two prior evidence implementation studies: long-term glucocorticoid (GC) users and nursing home (NH) residents with prior fracture or osteoporosis. Common practice setting was defined as doctors practicing at the same address or in the same nursing home. Alternating logistic regression evaluated the relationship between OP Rx, common practice setting, and individual physician treatment patterns.

Results

Among 6,281 GC users in 1,296 practices, the proportion receiving OP Rx in each practice was 6–100%. Among 779 NH residents in 66 nursing homes, the proportion in each NH receiving OP Rx was 0–100%. In both, there was no significant relationship between receipt of OP Rx and common practice setting after accounting for treatment pattern of individual physicians.

Conclusion

Physicians practicing together were not more alike in prescribing osteoporosis medications than those in different practices. Osteoporosis quality improvement may be able to ignore common practice settings and maximize statistical power by targeting individual physicians.

Keywords

Alternating logistic regression Fracture Glucocorticoid Group randomized trial Nursing home Osteoporosis 

Notes

Funding

This study was funded by a Pharma Foundation Research Grant in Health Outcomes, the Arthritis Foundation, the Agency for Healthcare Research and Quality (U18 HS016956), and the National Institutes of Health (AR053351, AR052361, AG024787). Dr. Colón-Emeric is also supported by the Durham VA Geriatric Research, Education, and Clinical Center.

Conflicts of interest

None.

Disclosures for unrelated projects

JRC: Consulting: Roche, UCB, Procter & Gamble; speakers bureau: Merck, Procter & Gamble, Eli Lilly, Roche, Novartis; research grants: Merck, Procter & Gamble, Eli Lilly, Amgen, and Novartis.

References

  1. 1.
    National Committee for Quality Assurance: State of Health Care Quality. 2006Google Scholar
  2. 2.
    Curtis JR, Westfall AO, Allison JJ et al (2005) Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 52(8):2485–2494CrossRefPubMedGoogle Scholar
  3. 3.
    Colon-Emeric C, Lyles KW, Levine DA et al (2007) Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture. Osteoporos Int 18(4):553–559CrossRefPubMedGoogle Scholar
  4. 4.
    Physician Voluntary Reporting Program. Centers for Medicare & Medicaid Services; 2007Google Scholar
  5. 5.
    Colon-Emeric CS, Casebeer L, Saag K et al (2005) Barriers to providing osteoporosis care in skilled nursing facilities: perceptions of medical directors and directors of nursing. J Am Med Dir Assoc 6(3 Suppl):S61–S66CrossRefPubMedGoogle Scholar
  6. 6.
    Brookhart MA, Solomon DH, Wang P, Glynn RJ, Avorn J, Schneeweiss S (2006) Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factors. J Clin Epidemiol 59(1):18–25CrossRefPubMedGoogle Scholar
  7. 7.
    Murray DM (1998) Design and analysis of group randomized trials . Oxford University Press, OxfordGoogle Scholar
  8. 8.
    Curtis JR, Westfall AO, Allison J et al (2007) Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial. Arch Intern Med 167(6):591–596CrossRefPubMedGoogle Scholar
  9. 9.
    Colon-Emeric CS, Lyles KW, House P et al (2007) Randomized trial to improve fracture prevention in nursing home residents. Am J Med 120(10):886–892CrossRefPubMedGoogle Scholar
  10. 10.
    Preisser JS, Arcury TA, Quandt SA (2003) Detecting patterns of occupational illness clustering with alternating logistic regressions applied to longitudinal data. Am J Epidemiol 158(5):495–501CrossRefPubMedGoogle Scholar
  11. 11.
    Feng Z, Diehr P, Peterson A, McLerran D (2001) Selected statistical issues in group randomized trials. Annu Rev Public Health 22:167–187CrossRefPubMedGoogle Scholar
  12. 12.
    Snijders TAB (2005) Power and sample size in multilevel linear models. In: Everitt BS, Howell DC (eds) Encyclopedia of statistics in behavioral science, vol 3. Chicester, Wiley, pp 1570–1573Google Scholar
  13. 13.
    Campbell MK, Thomson S, Ramsay CR, MacLennan GS, Grimshaw JM (2004) Sample size calculator for cluster randomized trials. Comput Biol Med 34(2):113–125CrossRefPubMedGoogle Scholar
  14. 14.
    Glynn RJ, Brookhart MA, Stedman M, Avorn J, Solomon DH (2007) Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers. Med Care 45(10 Supl 2):S38–S43CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2009

Authors and Affiliations

  • J. R. Curtis
    • 1
    Email author
  • T. Arora
    • 1
  • J. Xi
    • 2
  • A. Silver
    • 3
  • J. J. Allison
    • 1
  • L. Chen
    • 1
  • K. G. Saag
    • 1
    • 4
  • A. Schenck
    • 3
  • A. O. Westfall
    • 5
  • C. Colón-Emeric
    • 6
  1. 1.Center for Education and Research on TherapeuticsUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.Department of SociologyUniversity of AkronAkronUSA
  3. 3.The Carolinas Center for Medical ExcellenceCaryUSA
  4. 4.Department of EpidemiologyUniversity of Alabama at BirminghamBirminghamUSA
  5. 5.Department of BiostatisticsUniversity of Alabama at BirminghamBirminghamUSA
  6. 6.Duke University and the Durham VA Medical Center GRECCDurhamUSA

Personalised recommendations